Abstract
Obesity rates continue to rise worldwide, with a concomitant increase in co-morbidities, including metabolic disease, cardiovascular disease and cancer. The onset of obesity is most often characterized by an increase in the size of white adipose tissue fat cells (adipocyte hypertrophy) and secondary to this by adipocyte hyperplasia. Adipocyte hypertrophy is strongly linked to metabolic and cardiovascular disease with hypertrophy and not obesity per se, a predictor of type 2 diabetes.1 The contribution of visceral adipose tissue to these pathologies is even more pronounced.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
